Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide add-on therapy in children and adolescents with focal epilepsy
ChiCTR1900024507Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lacosamide in Focal Onset Epilepsy, sponsored by West China Second University Hospital. Primary endpoints: 50% response rate at 12 months and Seizure-free rate at 12 months. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
lacosamide
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on ChiCTR1900024507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024507.